Novadaq Technologies of Toronto has filed restated unaudited interim financial statements for the first quarter (end-March 31).
The developer of real-time medical imaging systems and image-guided therapies for the operating room said the restatement relates to accounting for cash flows of assets acquired from Edwards Lifesciences and the exclusive distribution rights to PLC Medical System's Heart Laser system for transmyocardial revascularization in the U.S.
The company added that the restatement has no impact on previously reported first-quarter net income, earnings per share, revenue, cash, total assets, or shareholder's equity.
By AuntMinnie.com staff writers
August 15, 2007
Related Reading
Novadaq grows sales and net loss in Q2, August 8, 2007
Novadaq nets Japanese patent for Spy, February 28, 2007
Novadaq gets Canadian approval for Luna, January 12, 2006
Novadaq begins trials for Luna system, October 23, 2006
Kodak named distributor for Novadaq’s Spy, September 11, 2006
Copyright © 2007 AuntMinnie.com